UBS Group AG Buys 87,014 Shares of Aehr Test Systems $AEHR
UBS Group AG increased its stake in Aehr Test Systems (NASDAQ:AEHR) by 55.7% in the fourth quarter, purchasing 87,014 additional shares to bring its total holding to 243,129 shares valued at $4.9 million. Wall Street analysts hold a mixed but neutral view on AEHR, with a consensus "Hold" rating and an average price target of $68.00. The company reported a smaller-than-expected quarterly loss of $0.05 per share, although revenue fell slightly short of estimates.
Aehr Test Systems to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference on May 28
Aehr Test Systems (NASDAQ: AEHR) announced that its CFO, Chris Siu, will participate in the 23rd Annual Craig-Hallum Institutional Investor Conference on May 28, 2026. Siu will hold one-on-one meetings with institutional investors at the event in Minneapolis. Aehr Test Systems is a leading provider of test and burn-in solutions for semiconductor devices across various high-growth applications like AI, automotive, and data centers.
What Does Aehr Test Systems' Q3 Earnings Tell Us About the Semiconductor Market
Aehr Test Systems (AEHR) reported challenging Q3 2026 results with a 44% revenue decrease and a net loss, but strong bookings and a record $50.9 million backlog signal robust future demand. The company is strategically poised to benefit from surging demand for AI processors, silicon photonics, and high-bandwidth memory. Despite near-term financial headwinds and valuation concerns, Aehr's crucial role in semiconductor reliability positions it as a compelling growth story, albeit with speculative elements.
Aehr Test CFO schedules investor meetings at May 28 Minneapolis conference
Aehr Test Systems CFO Chris Siu will participate in one-on-one meetings with institutional investors at the 23rd Annual Craig-Hallum Institutional Investor Conference on May 28, 2026, in Minneapolis. The announcement led to a 6.42% increase in AEHR stock, reflecting positive market reaction. Investors can schedule meetings through Craig-Hallum or Aehr's investor relations firm, PondelWilkinson, Inc.
Aehr To Deliver $41M Record Production Order to Hyperscale AI Customer
Aehr Test Systems, Inc. (Nasdaq: AEHR) has received a record-breaking $41 million production order from its leading hyperscale customer for package-level burn-in of custom AI processor ASICs. This order, the largest in the company's history, brings Aehr's bookings in the second half of its fiscal year to over $92 million to date. The products will be used by hyperscale cloud providers to optimize AI training and inference workloads.
Aehr Test Systems Stock Drops 16% In A Day, Why You Shouldn Not Be Buying The Stock
The article, titled "Aehr Test Systems Stock Drops 16% In A Day, Why You Shouldn Not Be Buying The Stock," discusses the significant daily decline in Aehr Test Systems' stock price. The content presented appears to be a stub or placeholder, as it primarily contains navigational and legal disclaimers rather than an in-depth analysis of the stock's performance or reasons for avoiding it.
Vanguard Group Inc. Has $47.19 Million Stock Position in Aehr Test Systems $AEHR
Vanguard Group Inc. increased its stake in Aehr Test Systems by 2.2% in the fourth quarter, now owning 7.63% of the company worth $47.19 million. Other institutional investors also made significant moves, with institutions and hedge funds collectively owning 69.69% of the stock. Aehr Test Systems shares have been volatile, and analysts have a mixed "Hold" consensus rating with an average price target of $68.
Assessing Aehr Test Systems (AEHR) Valuation After Strong Recent Share Price Momentum
Aehr Test Systems (AEHR) has experienced significant share price momentum, with a 35.89% return over the past month and a 349% year-to-date return, closing at US$99.50. Despite this, a prominent narrative by Arkus suggests the stock is overvalued, placing its fair value closer to $18.27 based on a discounted cash flow framework. Investors are encouraged to review underlying figures and consider the potential risks and opportunities before making investment decisions.
Will Mixed Q3 Results And A US$60M Equity Raise Change Aehr Test Systems' (AEHR) Narrative
Aehr Test Systems reported mixed fiscal third-quarter 2026 results and completed a US$60 million equity offering, leading to share dilution and increased scrutiny on AI chip demand. The company's investment narrative is now heavily dependent on the strength and timing of AI-related orders and the market's willingness to absorb further dilution. Despite balance sheet flexibility from the equity raise, the stock faces a rich valuation and active insider selling.
Aehr Test Systems Director Sold Shares Worth Over $714K
Slayen Howard T, a Director at Aehr Test Systems, sold 6,819 shares of Common Stock for $104.73 per share, totaling $714,153. Following this transaction, Slayen Howard T directly owns 169,709 shares of Common Stock, which includes unvested restricted stock units. This transaction was reported via an SEC Form 4 filing.
AEHR (AEHR) director Howard T. Slayen sells 6,819 shares, holds 169,709
Howard T. Slayen, a director at AEHR Test Systems (AEHR), sold 6,819 shares of the company's common stock in an open-market transaction at $104.73 per share. Following this sale, Slayen directly holds 169,709 shares, a figure which includes unvested restricted stock units. This transaction represents a net sale of $714,154 for the insider.
Will Mixed Q3 Results And A US$60M Equity Raise Change Aehr Test Systems' (AEHR) Narrative
Aehr Test Systems recently reported mixed fiscal Q3 2026 results and completed a US$60 million equity offering, leading to increased scrutiny on its investment narrative amid concerns about AI chip demand and insider activity. The equity raise provides financial flexibility but also heightens expectations for future performance. Investor perspectives on the company's fair value vary widely, indicating uncertainty about its long-term potential in a volatile market.
Aehr (AEHR) CFO Chris Siu sells 2,070 shares, retains over 75,000
Aehr Test Systems CFO Chris Siu reported selling a total of 2,070 company common stock shares. This included 1,600 shares indirectly through a trust at $106.78 each and 470 shares directly at $108.00 each through open-market sales. Following these transactions, Siu retains 70,270 shares directly and 5,706 shares indirectly, with a portion of these holdings subject to unvested restricted stock units.
Aehr Test Systems $AEHR is Halter Ferguson Financial Inc.'s 7th Largest Position
Halter Ferguson Financial Inc. significantly increased its stake in Aehr Test Systems (AEHR) by 41.7% in the fourth quarter, making it their seventh-largest holding. Despite the stock's volatility and recent insider selling, analysts expect an EPS of -0.31 for the current fiscal year. The company reported a smaller-than-expected loss of ($0.05) per share on $10.31 million in revenue.
Total debt per share of Aehr Test Systems – LS:908802
The article focuses on the "Total debt per share of Aehr Test Systems" (LS:908802) as listed on TradingView. It appears to be a financial data page, showing market data and linking to various tools and educational resources provided by TradingView, rather than presenting a detailed analysis of the debt itself. The content highlights the availability of financial information for Aehr Test Systems within the TradingView platform.
My Top 2 AI Stocks Flying Under the Radar for May 2026
This article identifies two under-the-radar AI stocks, Aehr Test Systems and ServiceNow, that investors should consider for May 2026. Aehr Test Systems, which tests AI chips, has seen significant growth due to large contracts and has an attractive valuation. ServiceNow, despite a recent downturn, is poised for recovery with strong performance obligations and a favorable valuation, making both compelling despite past market performance.
Aehr Test Systems (AEHR) director amends filing for 10,000-share gift
Aehr Test Systems director Geoffrey Scott Gates filed an amended insider report correcting the classification of a prior transaction. The update changes the transaction code from F to G, confirming a bona fide gift of 10,000 shares of Common Stock held indirectly through a trust. After this amendment, Gates holds 40,686 shares indirectly by a trust, 50,000 shares indirectly by his spouse, and 52,864 shares directly.
Winner of My Stock-Picking Derby Sold Her Top Pick Too Soon
Heather Fisher, a nurse from North Carolina, won a stock-picking contest with a 287% return, largely due to Aehr Test Systems (AEHR) which rose 849%. However, she sold most of her AEHR shares before its significant climb. The article also highlights other top performers and invites readers to participate in the upcoming contest.
Aehr Test Systems Stock Jumps as AI Orders Put $41 Million Win in Focus
Aehr Test Systems (NASDAQ: AEHR) saw its stock jump 6.5% after announcing a $41 million follow-on production order from its top hyperscale AI client for AI processor ASICs, with shipments starting in fiscal 2027. Despite a 44% decline in fiscal Q3 revenue and a net loss, investors are focusing on the company's strong bookings and exposure to the growing AI market. Management expects fiscal 2026 revenue at the high end of its $45 million to $50 million target, driven by increasing demand for burn-in testing in high-power AI processors and optical connections.
A Look At Aehr Test Systems (AEHR) Valuation After Record US$41 Million AI Order And Backlog Surge
Aehr Test Systems (AEHR) recently secured a record US$41 million AI order and saw its backlog nearly double, amidst an 81.61% share price increase over the last month. Despite this positive momentum, a popular narrative suggests the company is significantly overvalued, estimating its fair value at US$18.27 compared to its current price of US$91.26. Investors are urged to review the data and consider both the potential upside and the warning signs related to the company's valuation.
Aehr Test Systems stock hits all-time high at 102.71 USD
Aehr Test Systems (AEHR) stock reached an all-time high of $103.17, reflecting a staggering 983% one-year return, driven by strong demand for its semiconductor testing solutions. Despite this, InvestingPro analysis suggests the stock might be overvalued. The company recently completed a $60 million equity offering and secured a record $41 million production order for AI processor ASICs, leading analysts to adjust price targets upward.
Pier Capital LLC Has $4.27 Million Stock Holdings in Aehr Test Systems $AEHR
Pier Capital LLC significantly reduced its stake in Aehr Test Systems (NASDAQ:AEHR) by 43.0% in Q4, holding 211,619 shares valued at $4.27 million. Despite the company's recent stock run-up, it remains unprofitable with negative margins and EPS. Insiders have also been net sellers, offloading shares worth approximately $28.36 million in the last three months, though analysts maintain an average "Hold" rating with a target price of $68.
Aehr Test Systems Stock Surge April 2026: 144% Gain, Record $41M Order - News and Statistics
Aehr Test Systems experienced a significant stock surge of 144.2% in April 2026, driven by a record $41 million order from an existing hyperscale customer for its testing systems and burn-in modules. This gain occurred despite mixed fiscal third-quarter earnings, as investor confidence was boosted by a growing backlog of orders and the increasing adoption of burn-in testing for semiconductor chips. The stock has seen a 1,004% increase over the preceding 52 weeks, demonstrating strong market momentum.
FMR LLC holds 2,142,638 AEHR shares (NASDAQ: AEHR) in 13G/A filing
FMR LLC has filed an amended Schedule 13G/A, reporting beneficial ownership of 2,142,638.70 shares of AEHR Test Systems (NASDAQ: AEHR) common stock, which represents 7.0% of the class as of March 31, 2026. The filing indicates a passive investment intent, and Abigail P. Johnson is also listed with sole dispositive power over the same number of shares. This amendment updates a previous 13G filing, disclosing the current holdings and associated voting and dispositive powers.
Universal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 20,000 Aehr Test Systems $AEHR
Universal Beteiligungs und Servicegesellschaft mbH recently purchased 20,000 shares of Aehr Test Systems (AEHR) for an approximate value of $407,000, representing a 0.07% stake. This comes amidst significant insider selling, with CEO Gayn Erickson and Donald P. Richmond II disposing of substantial amounts of shares. Analyst ratings are mixed, with a consensus "Hold" rating and a $68 price target, despite several recent upgrades.
Aehr Test Systems (AEHR) Is Up 10.6% After Record Hyperscale AI Order And Growing Backlog – Has The Bull Case Changed?
Aehr Test Systems (AEHR) saw its stock rise by 10.6% following a record US$41 million order from a hyperscale AI customer and a significant increase in its order backlog. Despite this, the company reported a quarterly loss and completed an at-the-market equity program, leading to questions about its investment narrative. Investors are weighing the strong AI-driven order growth against revenue shrinkage, ongoing losses, and dilution risks highlighted by insider selling and recent share issuance.
ETFs Investing in Aehr Test Systems Stocks
This article lists various ETFs that hold shares of Aehr Test Systems (908802). It provides a detailed table including each ETF's market value, weight of Aehr in the portfolio, issuer, management style, expense ratio, assets under management (AUM), current price, daily percentage change, relative volume, and 3-year NAV total return. The ETFs cover different strategies, including passive and active management, and focus on small-cap, information technology, and theme-based investments, aiming to offer diversified opportunities for investors interested in Aehr Test Systems.
A Look At Aehr Test Systems (AEHR) Valuation After Record US$41 Million AI Testing Order
Aehr Test Systems (AEHR) recently secured a record US$41 million AI testing order, causing its share price to surge significantly. Despite this, the stock trades above the average analyst price target, leading to mixed signals about its valuation. Simply Wall St's analysis suggests AEHR is 409.4% overvalued, indicating that the market may already be pricing in future growth excessively.
Record Deal Wins Send Aehr Test (AEHR)’s Shares Up 140% In April
Aehr Test Systems (AEHR) saw its shares surge by 138.62% in April, driven by record deal wins in the hyperscale AI and silicon photonics markets. The company secured a historic $41 million order from its lead AI customer and additional business for next-generation AI accelerator ASICs, significantly boosting its fiscal 2026 bookings. These developments highlight Aehr Test Systems' growing role as a key enabler of AI infrastructure.
Are you looking for a top momentum pick? Why Aehr Test Systems (AEHR) is a great choice
This article identifies Aehr Test Systems (AEHR) as a strong momentum pick. It suggests that investors looking for stocks with upward price trends should consider AEHR. The content implies that the company exhibits characteristics aligning with a high-momentum investment strategy.
Aehr (AEHR) director reports 10,000-share disposition and updated holdings
Aehr Test Systems director Geoffrey Scott Gates reported a disposition of 10,000 common shares coded as a tax-withholding transaction, which were donated to a Charitable Gift Fund. Following this, his holdings include 40,686 shares indirectly through a trust, 50,000 shares indirectly by his spouse, and 52,864 shares held directly. The reported amounts also include shares subject to unvested restricted stock units.
Aehr Test Systems (AEHR) News, Articles, Events & Latest Updates
This page provides recent news and updates for Aehr Test Systems (AEHR), including information on its stock performance, market capitalization, and financial indicators such as PE ratio and EPS. Recent articles highlight analyst reports, insider transactions, and institutional investments, alongside news about the company's significant increase in short interest and a record AI hyperscaler order.
AEHR (AEHR) VP Sporck reports RSU tax withholding and updated share holdings
Alistair N. Sporck, VP of AEHR TEST SYSTEMS, reported on a routine equity transaction where 133 shares of common stock were withheld to cover tax obligations upon the vesting of restricted stock units. This withholding, valued at $88.48 per share, does not represent a sale by Sporck. Following this, he directly holds 20,161 shares and indirectly holds 5,177 shares through a trust, including unvested RSUs.
AEHR TEST SYSTEMS (AEHR) COO’s holdings adjust to 40,912 shares
AEHR TEST SYSTEMS' Chief Operating Officer, Adil Engineer, reported a tax-related share disposition where 143 shares were withheld to cover tax obligations upon the vesting of restricted stock units. This was not an open-market sale, and following this transaction, Engineer directly holds 40,912 shares, including unvested restricted stock units. The shares withheld were valued at $88.48 each.
Aehr Test Systems Raises US$60m Equity As Valuation And Volatility Loom
Aehr Test Systems successfully completed a $60 million follow-on equity offering to bolster its capital base. This move provides the company with increased financial flexibility, especially given its recent significant stock performance and current elevated valuation. Investors will now be watching how quickly management deploys these proceeds and what impact the increased share circulation has on volatility and future growth initiatives.
$Aehr Test Systems (AEHR.US)$ why keep selling, [Surprise]
The article describes a question from a user named "TheMillionQuest" about Aehr Test Systems ($AEHR.US$), asking "why keep selling," implying surprise at continued selling pressure on the stock. The content is embedded within the moomoo community platform.
State of Alaska Department of Revenue Makes New Investment in Aehr Test Systems $AEHR
The State of Alaska Department of Revenue has made a new investment in Aehr Test Systems (NASDAQ:AEHR), purchasing 18,675 shares valued at approximately $377,000. This investment gives them about 0.06% ownership of the semiconductor company, as revealed in a recent SEC filing. While institutional investors like Vanguard and Invesco have increased their stakes, company insiders have sold a significant number of shares, and the company reported a Q4 EPS of -$0.05, beating estimates but remaining unprofitable.
Aehr Test Systems: Small AI Stock Sees Record AI Hyperscaler Order
Aehr Test Systems (AEHR) has seen its stock soar over 350% in 2026 due to increasing demand from AI customers. The company recently received a record $41 million order for its Sonoma systems from a lead hyperscale customer, pushing its H2 FY2026 orders to over $92 million, significantly exceeding previous forecasts. Aehr is also working with this customer on next-generation AI processor ASICs, indicating continued growth opportunities, and recently issued shares to expand production capacity.
Aehr Test Systems: Small AI Stock Sees Record AI Hyperscaler Order
Aehr Test Systems (NASDAQ: AEHR), a small semiconductor stock, has seen its shares soar over 350% in 2026 due to increasing demand from AI customers. The company recently secured a record $41 million order from a lead hyperscale customer for its Sonoma systems, which test AI processor ASICs. This order, along with others, has pushed Aehr's H2 FY2026 orders to over $92 million, significantly exceeding previous forecasts.
Aehr Test Systems stock hits all-time high at 99.66 USD
Aehr Test Systems (AEHR) stock reached an all-time high of $99.66, reflecting a 1,029% surge over the past year. Despite its strong performance driven by advancements in semiconductor testing, an InvestingPro analysis suggests the stock may be overvalued. The company recently completed a $60 million stock offering and secured a record $41 million order for AI processor ASICs, with analysts maintaining positive price targets.
Aehr Test Systems Insiders Sold Shares Worth Over $4.5M
Aehr Test Systems insiders, Alberto Salamone and Posedel Rhea J, recently sold shares totaling over $4.5 million. Salamone sold 30,000 shares across two transactions for approximately $2.76 million, while Posedel Rhea J sold shares for about $1.77 million. These sales were reported through SEC Form 4 filings.
Aehr Test Systems director Posedel sells $1.77m in stock
Rhea J. Posedel, a director at AEHR Test Systems (NASDAQ:AEHR), sold common stock worth $1,768,880 on April 22, 2026, as the stock traded near its 52-week high after a 1,029% gain over the past year. The sale involved 17,115 direct shares and 604 indirect shares through a trust. InvestingPro analysis suggests the stock may be overvalued, despite the company recently completing a $60 million stock offering and receiving a record $41 million production order.
Director at Aehr Test Systems (AEHR) trims holdings in April stock sale
Aehr Test Systems director Rhea J. Posedel reported open-market sales of company stock on April 22, 2026, totaling 17,719 shares. This included an indirect sale of 604 shares at $95.00 through a trust and a direct sale of 17,115 shares at $100.00. Following these transactions, Posedel holds 396,375 shares indirectly via a trust (including unvested RSUs) and 45,261 shares directly, indicating a partial reduction rather than a complete divestment.
If You Invested $100 In Aehr Test System Stock 10 Years Ago, You Would Have This Much Today
Aehr Test System (NASDAQ: AEHR) has demonstrated strong market outperformance over the past decade, with an average annual return of 52.83%. An initial investment of $100 in AEHR stock ten years ago would now be valued at $6,536.42, highlighting the significant impact of compounded returns. The company currently holds a market capitalization of $3.04 billion.
Aehr Test Systems Insider Sold Shares Worth $5,660,000, According to a Recent SEC Filing
An insider at Aehr Test Systems sold shares valued at $5,660,000, as reported in a recent SEC filing. This transaction is part of a series of insider sales from the company, with other filings indicating sales of $660,675, $2,125,000, and $1,210,800 in shares this month. Aehr Test Systems, a semiconductor equipment and testing company, recently completed a $60 million sale of common shares and received a $41 million production order from an AI customer.
Aehr Test Systems (NASDAQ: AEHR) EVP sells 5,000 shares
Vernon Rogers, EVP of Sales & Marketing at Aehr Test Systems (NASDAQ: AEHR), sold 5,000 shares of common stock at $90.00 per share in an open-market transaction. Following this sale, Rogers directly holds 147,716 shares, which include unvested restricted stock units. This transaction represents a routine sale by a company executive.
Aehr Test Systems Exec VP of Sales & Mktg. Sold Shares Worth Over $610K
Vernon Rogers, an Executive VP of Sales & Marketing at Aehr Test Systems, sold 6,486 shares of common stock for over $610K. Additionally, Director Rhea J. Posedel sold common stock totaling $843,756. These transactions leave Rogers with 152,716 directly owned shares and Posedel with 62,376 directly owned shares and 396,979 indirectly owned shares.
Aehr Test Systems (AEHR) EVP sells shares, holds 152K total
Aehr Test Systems' Executive Vice President of Sales and Marketing, Vernon Rogers, sold 6,486 shares of common stock at $94.0904 per share. Following this transaction, Rogers directly holds 152,716 shares, which includes unvested restricted stock units. This open-market sale, detailed in a Form 4 filing, represents a small percentage of his total reported holdings.
Assessing Aehr Test Systems (AEHR) Valuation After A Sharp Share Price Surge
Aehr Test Systems (AEHR) has experienced a significant share price surge, with strong returns over the past month, three months, and year-to-date, suggesting investors are rapidly re-evaluating its prospects. Despite its current net loss of US$11.42 million on US$45.26 million in revenue, the company trades at a high Price-to-Book ratio of 20.4x, indicating that the market has high expectations for future growth. Simply Wall St's analysis suggests the stock is currently overvalued based on this metric, implying significant risk if future growth does not meet these elevated expectations.
Aehr Test Systems completes $60 million at-the-market stock offering
Aehr Test Systems (NASDAQ:AEHR) has completed a $60 million at-the-market (ATM) stock offering, selling common stock near its 52-week high, despite an InvestingPro analysis suggesting the stock is overvalued. This capital raise follows a record $41 million order for AI processor ASICs and mixed Q3 2026 financial results, which included an EPS beat but a revenue miss. Analysts have, however, raised price targets due to strong booking momentum, pushing the company's backlog over $50 million.
